These distinctive characteristics position calgranulin C as a promising candidate for an IBD biomarker; however, its clinical utility remains, as S100A12 has also been implicated in other inflammatory conditions [158,220,238]. This evidence concerns the gene S100A12 and irritable bowel syndrome.